Optimising Clinical Success With Foundational Heart Failure Treatment

Published: 05 December 2022

  • Views:

    Views Icon 7959

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This video series is dedicated to the adoption of patient-reported outcomes (PROs) and initiation of guideline-directed medical therapy (GDMT) in daily practice. 

 

In this first discussion, Prof Andrew Coats (Heart Research Institute, Sydney, AU) and Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, Kansas City, US) address how to optimise clinical success using foundational heart failure treatment. 

 

Split into three short videos, Prof Coats and Dr Kosiborod start by summarising current foundational heart failure therapy and how guidance has recently changed across the spectrum of ejection fraction. Following this, they explore recent evidence supporting initiation of GDMT and offer practical advice for the implementation of treatment, including possible solutions to the early uptake of GDMT.

 

The full series of videos entitled 'Incorporating GDMT and PRO Endpoints for Personalised Heart Failure Management' is available to watch, or you can take the course to earn 1 CME credit. 

 

Watch Full Series
Earn 1 CME Credit

 

This programme is supported by an unrestricted educational grant from AstraZeneca.

Key Learning Objectives

  • Review current GDMT in HFrEF and HFpEF
  • Describe the relationship between initiation of GDMT and HF outcomes
  • Prescribe GDMT according to current international recommendations

Target Audience

  • Cardiologists
  • Heart Failure Specialists
  • Primary Care Physicians
  • Nurses
  • Pharmacists
  • Other allied HCPs

More from this programme

Part 1

What is GDMT?

In this opening video, Prof Coats and Dr Kosiborod summarise foundational GDMT across the spectrum of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF).

1 session
What is GDMT? Watch now

Part 2

Early Initiation and Better Clinical Outcomes

Prof Coats and Dr Kosiborod discuss the relationship between early initiation of foundational GDMT and better clinical outcomes by exploring recent clinical trial data from STRONG-HF.
1 session
Early Initiation and Better Clinical Outcomes Watch now

Part 3

Achieving Early Uptake of GDMT

In this final part, Prof Coats and Dr Kosiborod cover practical approaches for ensuring early optimal GDMT in heart failure, such as, the use of electronic health records and protocols for specific patient subgroups.
1 session
Achieving Early Uptake of GDMT Watch now

Faculty Biographies